Influence of Self-Expanding Paclitaxel-Eluting Stent Sizing on Neointimal Hyperplasia in Superficial Femoral Artery Lesions
Open Access
- 25 September 2020
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 84 (10), 1854-1861
- https://doi.org/10.1253/circj.cj-20-0470
Abstract
Background:Although self-expanding drug-eluting stents (DES) have recently shown superior outcomes for superficial femoral artery (SFA) lesions, optimal sizing of DES diameter in SFA intervention is unclear. Methods and Results:A total of 40 de novo SFA lesions were randomized 1:1 to receive self-expanding DES with either a 1-mm or 2-mm larger diameter than the reference vessel diameter. Follow-up optical coherence tomography (OCT) was scheduled 6 months after DES implantation to evaluate the vascular response to the stents. Volume index (VI) was defined as volume divided by stent length. The primary endpoint was neointimal VI at 6 months. Baseline reference vessel diameter was similar between the 1-mm larger diameter group and the 2-mm larger diameter group (5.0±0.8 mm vs. 4.7±0.9 mm, P=0.35). Stent diameter was 6.3±0.6 mm in the 1-mm larger group and 7.1±0.6 mm in the 2-mm larger group (P2vs. 9.6±3.4 mm2, PConclusions:Implantation of self-expanding DES with a considerably high SV ratio resulted in neointimal hyperplasia in SFA lesions.Keywords
This publication has 20 references indexed in Scilit:
- Duplex criteria for in‐stent restenosis in the superficial femoral arteryCatheterization and Cardiovascular Interventions, 2012
- Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal DiseaseCirculation: Cardiovascular Interventions, 2011
- Optical coherence tomography patterns of stent restenosisAmerican Heart Journal, 2009
- Influence of Stent Fracture on the Long-Term Patency in the Femoro-Popliteal Artery: Experience of 4 YearsJACC: Cardiovascular Interventions, 2009
- Late Stent Expansion and Neointimal Proliferation of Oversized Nitinol Stents in Peripheral ArteriesCardioVascular and Interventional Radiology, 2009
- Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional StentingJournal of the American College of Cardiology, 2007
- Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral ArteryThe New England Journal of Medicine, 2006
- Molecular Basis of Restenosis and Drug-Eluting StentsJournal of the American College of Cardiology, 2005
- Prevalence and clinical impact of stent fractures after femoropopliteal stentingJournal of Invasive Cardiology, 2005
- Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug DeliveryJournal of the American College of Cardiology, 1997